Vertex Pharmaceuticals Inc.’s nonaddictive drug for lower back pain didn’t do better than a placebo ... If approved, Vertex’s ...

The company’s suzetrigine is one of the most-watched medicines across all the drug pipelines in the biotech sector.

Vertex Pharmaceuticals' suzetrigine shows promising results in treating painful lumbosacral radiculopathy, but stock falls ...

Vertex's closely watched drug, suzetrigine, reduced sciatica pain compared to baseline but did not outperform a placebo ...

Lower back pain is a problem most people face at some point, affecting about 8 out of 10 individuals in their lives.

Cellular research indicates that neuropilin-1 plays a crucial role in pain signaling, presenting a potential pathway for ...

Scientists at Weill Cornell Medicine and the Burke Neurological Institute have developed a groundbreaking drug that may ...

Mixed results from a study focused on lower back pain left analysts wanting as well as confused about Vertex's plans to forge ...

It’s clear that CrossFit provides a range of benefits, and recently, researchers set out to explore if it could also reduce ...

Nerve pain is typically treated with prescription-strength medications, but some over-the-counter products, primarily topical creams and ointments, can help take the edge off. Nerve pain can be ...

Scientists are now using artificial intelligence (AI) for drug discovery in advanced ... Oct. 2, 2024 — A new study showed that reducing daily sitting prevented back pain from worsening over six ...

Dangerous side effects from the injectable canine drug Librela — used to treat osteoarthritis joint pain — have been linked to seizures, lameness and loss of muscle control, the FDA warned.